Open the latest COVID treatment guidelines for favipiravir, children under 18 years old – pregnant women can add LAAB as a drug – help people access

Department of Medical Services, Ministry of Public Health (MoPH) disseminates guidelines for medical practice, diagnosis, treatment and prevention of hospital infections. Coronavirus Disease 2019 (COVID-19) Case for Doctors and Public Health Personnel The revised version dated 30 November 2022, with two main points: 1. Adjustment of antiretroviral drugs in adults and in children according to various symptom groups 2. Adjustment of Long Acting Antibody (LABB)

for adjusting the antiviral drug In the case of children under 18 years of age with mild symptoms no pneumonia no risk factors Take care according to the symptoms. Favipiravir may be given for 5 days. In pregnant women, favipiravir can be used in the second and third trimesters if indicated and the benefit outweighs the risks. The decision is made with patients and relatives.

While an increase in long acting antibody (LABB) is recommended in patients aged 12 years and over and weighing 40 kg or more, the recommended LAAB dosage is the same as for adults.

Reporters report that adding LAAB as a drug to treat COVID-19 It will help people have more access to expensive medicines. The drug is priced at 29,000 baht/via.

Incidentally, canRead full details here.